Patient self-administration of a nitrous oxide/oxygen combination appears to be superior to oxygen alone as an adjunct analgesic treatment for severe breakthrough cancer pain.
Self-guided online cognitive behavioral pain management may result in improved "worst" pain but not "average" pain compared with usual care for the treatment of painful chemotherapy-induced peripheral neuropathy.
Abstinent smokers may have reduced preoperative pain tolerance and increased postoperative opioid use compared with nonsmokers.
A single-center analysis demonstrates likelihood that mastalgia indicates presence of breast cancer and extensiveness of common work-up for the complaint. These findings were presented at SABCS 2017.
A report on current legislation and practice trends regarding opioids and how they are affecting cancer patients' ability to manage their pain.
Results of a recent study showed that neuropathic cancer pain (NCP) in patients with cancer was not only associated with a worsened quality of life but is also not adequately managed.
Behavior assessment tool (BPAT) measures pain in critically ill patients who cannot communicate verbally.
Nicotinamide riboside, a type of B3 vitamin, was shown to prevent chemotherapy-induced peripheral neuropathy in an animal-model study.
A single 8-Gy dose of radiotherapy for painful bone metastases may improve quality of life and pain as early as 10 days after administration.
Cancer survivors who reported chronic neuropathic pain 5 years after diagnosis were approximately 50% less likely to retain their jobs than those without chronic neuropathic pain.
Sublingual fentanyl is used to manage breakthrough pain in adults with cancer who are already receiving opioid therapy for underlying persistent cancer pain. In this study, researchers evaluated the effect of low doses of sublingual fentanyl in patients who are receiving low opioid doses for background analgesia.
Patient abuse of opioids costs the U.S. economy $78.5 billion a year, including the costs of health care, lost productivity, and treatment programs.
Approaches such as acupuncture, massage, and tai chi may ease discomfort when other therapy fails.
Pain response—sensitivity and tolerance—after use of active cannabis differs between men and women.
Cancer survivors who are nonwhite, less educated, older, and/or have comorbidities were less likely to receive adequate cancer pain management.
Massage therapy may be promising for reducing the intensity/severity of pain, fatigue, and anxiety in patients with cancer.
Despite the infrequency of urine drug test ordering, greater than half of all urine drug tests results were abnormal among outpatients with advanced cancer.
Methadone appears to be superior to fentanyl for the treatment of neuropathic pain in patients with head and neck cancer.
Recurrent disease, second malignancy, late-onset treatment effects should be assessed in patients with new pain, according to the new guidelines.
Risk factors for chronic pain after breast cancer surgery include axillary lymph node dissection, younger age, and radiation therapy. Only axillary lymph node dissection is a high-yield target for a modifiable risk factor to prevent the persistent pain after breast cancer surgery.
Managing pain with opioids and keeping a close eye on adverse effects is an important part of cancer care. But there is room for improvement in pain management tools, and nurses play a key role in their evolution.
Quality of life for patients with oral cancer can be dismal due to cancer-related pain. An NIDCR grant is supporting the investigation of a nonviral gene delivery method for treating oral cancer pain safely and effectively.
Recent research using rats indicates that gene therapy might treat the neuropathic pain that affects 90% of patients with cancer.
Video-assisted thoracoscopic surgery (VATS) is associated with less postoperative pain and better quality of life than anterolateral thoracotomy for the first year of surgery in patients with stage I NSCLC.
All opioids are currently recommended for breakthrough cancer pain and clinicians may use the opioid of their choice.
Treatment of breakthrough cancer pain is an important component of care for patients, and nurses should consider various factors when titrating the dose of fentanyl sublingual spray to an effective dose.
Neurofeedback Training Enables Cancer Survivors to Control Chemotherapy-Induced Peripheral NeuropathyApril 01, 2016
Chronic pain was decreased and quality of life was increased through neurofeedback.
Despite its prevalence in patients receiving taxane-based chemotherapies, taxane acute pain syndrome (TAPS) remains poorly researched.
Moderate to heavy drinking might cut the likelihood of disability for people with chronic widespread pain.
Researchers have found that combined use of antidepressants and NSAID painkillers is associated with an increased risk of bleeding.
Sign Up for Free e-newsletters
- Managing Chemo Brain in Pediatric Survivors of Childhood Cancer
- A Witness to Letting Go: Nursing Care at the End of Life
- CHEMO-SUPPORT: A Nursing Intervention to Relieve Chemotherapy Symptom Burden
- Excretion of Volatile Organic Compounds Higher in AYAs Using Vaping Products
- Risk for Cardiovascular Disease Higher in Survivors of Testicular Cancer
- Various Aspects of Palliative Care Focus Associated With Different Outcomes In Cancer
- Cost vs Benefits: The Controversy Over Proton Beam Radiotherapy
- Patient Expectations at Odds With Actual Outcomes for Radiotherapy in Breast Cancer
- Patients Desire More Online Tools and Access
- Metformin Plus Ruxolitinib: A Potential Therapeutic Alternative for Myeloproliferative Neoplasms
- Androgen-Deprivation Therapy for Prostate Cancer May Cause Nocturia, Sleep Disturbance
- USPSTF Rates Ovarian Cancer Screening a D for Asymptomatic, Low-Risk Women
- Colorectal Cancer Screening Rate Increased by Digital Self-Ordering
- Presence of Iris Pigmented Lesions Indicates Melanoma Risk
- A Witness to Letting Go: Nursing Care at the End of Life
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|